Ing Investment Management »

Enliven Therapeutics shares owned by Ing Investment Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $298k 12k 25.54
2024-06-30 $277k 12k 23.37